Skip to content
Fasting

Medicare GLP‑1 Bridge confirms coverage of Foundayo, Wegovy, Zepbound KwikPen

New July 1, 2026 Medicare guidance confirms Medicare GLP‑1 Bridge covers Foundayo, all Wegovy options, and only Zepbound KwikPen for weight‑loss under $50/month.

By
Ian Gauntt, RN, BSN
Published
Read time
3 min
Doctor typing on computer in office

Key Takeaways

  • Medicare GLP‑1 Bridge covers Foundayo tablets, all Wegovy forms, and only Zepbound KwikPen starting July 1, 2026.
  • Eligible seniors with Part D pay $50/month for these weight‑loss GLP‑1s, outside Part D cost‑sharing.
  • Single‑dose Zepbound vials or pens remain excluded from coverage.
  • Providers must submit prior authorization under Bridge using correct product form and indication.
  • Program runs from July 1, 2026 to December 31, 2027 with central CMS processing.

What does Medicare GLP‑1 Bridge cover starting July 1, 2026?

Medicare GLP‑1 Bridge covers Foundayo tablets. It covers all formulations of Wegovy—injection or pill. It includes only the KwikPen formulation of Zepbound; single‑dose pens or vials don't qualify (cms.gov). Beneficiaries pay $50 per month, outside of Part D cost‑sharing (medicare.gov).

Who qualifies and what do providers need to do?

Seniors need Medicare Part D through a standalone PDP or an MA‑PD plan. They must meet clinical criteria at therapy initiation—typically BMI thresholds or related conditions (cms.gov). Providers must send prescriptions with the note "SEND TO MEDICARE GLP‑1 BRIDGE FOR WEIGHT MANAGEMENT" and route prior authorization to CMS's central processor (cms.gov).

How long does the program run and what's next?

The Medicare GLP‑1 Bridge runs from July 1, 2026 through December 31, 2027 (cms.gov). CMS will collect data before BALANCE or broader coverage models may follow. The fixed $50 copay sits outside standard Part D payment flow to simplify administration (cms.gov).

FAQ

What is the Medicare GLP‑1 Bridge?

Medicare GLP‑1 Bridge is a short‑term demonstration that lets eligible Medicare Part D beneficiaries access certain GLP‑1 weight‑loss drugs for $50 a month outside normal Part D coverage.

Which GLP‑1 drugs does the Medicare GLP‑1 Bridge cover?

It covers Foundayo tablets, all Wegovy formulations (injection and oral), and only the Zepbound KwikPen. Single‑dose Zepbound pens or vials aren't included.

How much do seniors pay under Medicare GLP‑1 Bridge?

Seniors pay a flat $50 per month for covered GLP‑1 weight‑loss drugs through the Medicare GLP‑1 Bridge; this cost doesn't count toward deductibles or out‑of‑pocket limits.

Do providers need to meet clinical criteria to prescribe under the Medicare GLP‑1 Bridge?

Yes. Providers must certify the patient met Medicare's GLP‑1 Bridge clinical criteria—typically BMI thresholds or comorbidities—at therapy start, even if therapy began before July 1, 2026.

When does the Medicare GLP‑1 Bridge end?

The program runs from July 1, 2026 through December 31, 2027. CMS may extend or replace it with models like BALANCE afterward.

Not medical advice. GLP‑1 medications are prescription drugs and fasting is not right for everyone—talk to a licensed healthcare provider before starting, stopping, or changing any treatment or eating pattern.

Sources

Where this comes from

This article is educational, not medical advice. GLP-1 therapy and fasting decisions belong in a conversation with a clinician who knows your history.

Keep reading

The Slow Letter

Careful, source-checked notes on GLP-1s and fasting — no hype, no fear.

One measured email when there's something worth saying. Unsubscribe any time.

We never sell or share your address. Privacy